Table 1.
Characteristics of the study cohort. Data are presented as number (%) or median values (25, 75 percentiles)
| Age (years)(range) | 75 (70,82) |
| Males | 210 (70.2) |
| BMI (kg/m2) | 25.6 (23.8, 28.3) |
| Systolic BP (mmHg) | 140 (125, 151) |
| Diastolic BP (mmHg) | 74 (67, 80) |
| Current smokers | 41 (13.7) |
| Previous hyperlipidemia | 156 (47.8) |
| Previous hypertension | 182 (60.9) |
| Diabetes mellitus | 69 (23.1) |
| Previous chronic kidney disease1 | 15 (5.1) |
| Previous heart failure | 16 (5.4) |
| Previous coronary artery disease | 135 (45.2) |
| Previous ischaemic stroke | 21 (7.0) |
| NSTEMI/STEMI | 68.6 / 31.4 (205 / 94) |
| 3-vessel disease2 | 61 (21.3) |
| Maximum Troponin T (ng/L) | 700 (153, 2500) |
| NT-proBNP (ng/L) | 634 (279, 1374) |
| LVEF < 50%3 | 52 (32.1) |
| Taking n-3 FA supplement | 135 (45.2) |
BMI Body Mass Index; NSTEMI Non-ST-segment elevation myocardial infarction; STEMI ST-segment elevation myocardial infarction; NT-proBNP N-terminal pro-Brain natriuretic peptide; LVEF Left ventricle ejection fraction; FA fatty acids
1creatinine > 150 μmol/L
2 of n = 286 with angiography
3 of n = 162 with echocardiography